Cangene Advances Alzheimer's Disease Research with Technology Developed at UBC

News   Sep 16, 2013

 
Cangene Advances Alzheimer's Disease Research with Technology Developed at UBC
 
 
 
 

RELATED ARTICLES

Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS Vaccine

News

The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.

READ MORE

CRISPR Reveals New Targets for Promising Cancer Drugs

News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

READ MORE

Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

News

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE